Abstract
The Fourth Annual PepTalk meeting organized by the Cambridge Healthtech Institute on proteomics was held in San Diego, California from January 10 to 13, 2005. The entire meeting had an interesting name: Proteomics in a Six- Pack, and consisted of six individual meetings that ran for two days each, in two groups of concurrent sessions: (1) Fourth Annual Protein Arrays: Complex Challenges - Creative Solutions (January 10-11); (2) Eighth Annual Protein Expression (January 10-11); (3) Inaugural Protein Folding Disorders (January 10-11); (4) Second Annual Protein Process Development: Optimizing Protein Expression Through Scale-Up (January 12-13); (5) Fifth Annual The Human Proteome: Plasma Proteomics (January 12-13); and (6) Inaugural Protein Therapeutics: Minimizing Problems - Maximizing Production, Progress, and Potential (January 12-13). This was indeed what the organizers called the “protein information week”. This report summarizes The Human Proteome meeting, which ended with a joint closing plenary session with the Protein Process Development and the Protein Therapeutics meetings.
Keywords: proteomics, human proteome, plasma proteomics
Current Proteomics
Title: Meeting Report: The Fourth Annual PepTalk Meeting: The Human Proteome
Volume: 2 Issue: 1
Author(s): Sean R. Gallagher
Affiliation:
Keywords: proteomics, human proteome, plasma proteomics
Abstract: The Fourth Annual PepTalk meeting organized by the Cambridge Healthtech Institute on proteomics was held in San Diego, California from January 10 to 13, 2005. The entire meeting had an interesting name: Proteomics in a Six- Pack, and consisted of six individual meetings that ran for two days each, in two groups of concurrent sessions: (1) Fourth Annual Protein Arrays: Complex Challenges - Creative Solutions (January 10-11); (2) Eighth Annual Protein Expression (January 10-11); (3) Inaugural Protein Folding Disorders (January 10-11); (4) Second Annual Protein Process Development: Optimizing Protein Expression Through Scale-Up (January 12-13); (5) Fifth Annual The Human Proteome: Plasma Proteomics (January 12-13); and (6) Inaugural Protein Therapeutics: Minimizing Problems - Maximizing Production, Progress, and Potential (January 12-13). This was indeed what the organizers called the “protein information week”. This report summarizes The Human Proteome meeting, which ended with a joint closing plenary session with the Protein Process Development and the Protein Therapeutics meetings.
Export Options
About this article
Cite this article as:
Gallagher R. Sean, Meeting Report: The Fourth Annual PepTalk Meeting: The Human Proteome, Current Proteomics 2005; 2 (1) . https://dx.doi.org/10.2174/1570164053507817
DOI https://dx.doi.org/10.2174/1570164053507817 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Role of Mitochondria in Cancer Induction, Progression and Changes in Metabolism
Mini-Reviews in Medicinal Chemistry Recent Advances and Strategies in Tumor Vasculature Targeted Nano-Drug Delivery Systems
Current Pharmaceutical Design RAN GTPase as a Target for Cancer Therapy: Ran Binding Proteins
Current Molecular Medicine Chagas Disease Chemotherapy: What Do We Know So Far?
Current Pharmaceutical Design The Stem Cell Factor Receptor/c-Kit as a Drug Target in Cancer
Current Cancer Drug Targets CYP24A1 as a Potential Target for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Evidence for Predominance of CCR5-Using HIV-1 Strains During Highly Active Antiretroviral Therapy
Current HIV Research A Comprehensive Review on Pharmacology and Toxicology of Bioactive Compounds of <i>Lagerstroemia Speciosa(L.</i>) Pers.
Current Traditional Medicine MicroRNA-16-5p Controls Development of Osteoarthritis by Targeting SMAD3 in Chondrocytes
Current Pharmaceutical Design EXTraordinary Bones: Functional and Genetic Analysis of the EXT Gene Family
Current Genomics Distinctive Cellular Roles for Novel Protein Kinase C Isoenzymes
Current Pharmaceutical Design Notch-Associated MicroRNAs in Cancer
Current Drug Targets Telomere Recombination and the ALT Pathway: A Therapeutic Perspective for Cancer
Current Pharmaceutical Design Aldose Reductase Inhibitor, Fidarestat Prevents High-fat Diet-induced Intestinal Polyps in ApcMin/+ Mice
Current Cancer Drug Targets miR-126 as a Therapeutic Agent for Diabetes Mellitus
Current Pharmaceutical Design Anticancer Chemodiversity of Ranunculaceae Medicinal Plants: Molecular Mechanisms and Functions
Current Genomics Natural Product Inhibitors of the Ubiquitin-Proteasome Pathway
Current Drug Targets Peripheral Benzodiazepine Receptor (PBR) New Insight in Cell Proliferation and Cell Differentiation Review
Current Clinical Pharmacology Ewing Sarcoma Family Tumors: Past, Present and Future Prospects
Current Cancer Therapy Reviews Diabetic Bone Fracture Repair: A Progenitor Cell-Based Paradigm
Current Stem Cell Research & Therapy